Abstract
The in vitro activities of new beta-lactam antibiotics and new quinolones were studied against 96 Capnocytophaga strains, including a beta-lactamase-producing strain which was resistant to ampicillin, amoxicillin, carbenicillin, cephalothin, and cefamandole. All strains were susceptible to the combination of amoxicillin and clavulanic acid, ureidopenicillins, cefoxitin, broad-spectrum cephalosporins, and imipenem. Cephalothin and cefamandole did not show good activity against most strains. All Capnocytophaga spp. were uniformly susceptible to the five new quinolones tested.
Full text
PDF![1283](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f49/174921/8846aa05ddf6/aac00098-0145.png)
![1284](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f49/174921/602279a1aa42/aac00098-0146.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Forlenza S. W., Newman M. G., Horikoshi A. L., Blachman U. Antimicrobial susceptibility of Capnocytophaga. Antimicrob Agents Chemother. 1981 Jan;19(1):144–146. doi: 10.1128/aac.19.1.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forlenza S. W., Newman M. G., Lipsey A. I., Siegel S. E., Blachman U. Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients. Lancet. 1980 Mar 15;1(8168 Pt 1):567–568. doi: 10.1016/s0140-6736(80)91057-0. [DOI] [PubMed] [Google Scholar]
- Hawkey P. M., Smith S. D., Haynes J., Malnick H., Forlenza S. W. In vitro susceptibility of Capnocytophaga species to antimicrobial agents. Antimicrob Agents Chemother. 1987 Feb;31(2):331–332. doi: 10.1128/aac.31.2.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kristiansen J. E., Bremmelgaard A., Busk H. E., Heltberg O., Frederiksen W., Justesen T. Rapid identification of Capnocytophaga isolated from septicemic patients. Eur J Clin Microbiol. 1984 Jun;3(3):236–240. doi: 10.1007/BF02014892. [DOI] [PubMed] [Google Scholar]
- Laughon B. E., Syed S. A., Loesche W. J. API ZYM system for identification of Bacteroides spp., Capnocytophaga spp., and spirochetes of oral origin. J Clin Microbiol. 1982 Jan;15(1):97–102. doi: 10.1128/jcm.15.1.97-102.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mashimo P. A., Yamamoto Y., Nakamura M., Slots J. Selective recovery of oral Capnocytophaga spp. with sheep blood agar containing bacitracin and polymyxin B. J Clin Microbiol. 1983 Feb;17(2):187–191. doi: 10.1128/jcm.17.2.187-191.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parenti D. M., Snydman D. R. Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts. J Infect Dis. 1985 Jan;151(1):140–147. doi: 10.1093/infdis/151.1.140. [DOI] [PubMed] [Google Scholar]
- Rummens J. L., Gordts B., Van Landuyt H. W. In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents. Antimicrob Agents Chemother. 1986 Nov;30(5):739–742. doi: 10.1128/aac.30.5.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Socransky S. S., Holt S. C., Leadbetter E. R., Tanner A. C., Savitt E., Hammond B. F. Capnocytophaga: new genus of gram-negative gliding bacteria. III. Physiological characterization. Arch Microbiol. 1979 Jul;122(1):29–33. doi: 10.1007/BF00408042. [DOI] [PubMed] [Google Scholar]
- Sutter V. L., Pyeatt D., Kwok Y. Y. In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents. Antimicrob Agents Chemother. 1981 Aug;20(2):270–271. doi: 10.1128/aac.20.2.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walker C. B., Niebloom T. A., Socransky S. S. Agar medium for use in susceptibility testing of bacteria from human periodontal pockets. Antimicrob Agents Chemother. 1979 Oct;16(4):452–457. doi: 10.1128/aac.16.4.452. [DOI] [PMC free article] [PubMed] [Google Scholar]